DrugCite
Search

IFOSFAMIDE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Ifosfamide Adverse Events Reported to the FDA Over Time

How are Ifosfamide adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Ifosfamide, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Ifosfamide is flagged as the suspect drug causing the adverse event.

Most Common Ifosfamide Adverse Events Reported to the FDA

What are the most common Ifosfamide adverse events reported to the FDA?

Febrile Neutropenia
378 (3.74%)
Neutropenia
263 (2.6%)
Encephalopathy
196 (1.94%)
Thrombocytopenia
178 (1.76%)
Mucosal Inflammation
173 (1.71%)
Pyrexia
137 (1.35%)
Vomiting
118 (1.17%)
Nausea
111 (1.1%)
Infection
106 (1.05%)
Sepsis
103 (1.02%)
Anaemia
92 (.91%)
Show More Show More
Neurotoxicity
91 (.9%)
Pancytopenia
90 (.89%)
Confusional State
85 (.84%)
Acute Myeloid Leukaemia
83 (.82%)
Death
83 (.82%)
Leukopenia
80 (.79%)
Renal Failure Acute
75 (.74%)
Pneumonia
74 (.73%)
Febrile Bone Marrow Aplasia
69 (.68%)
Myelodysplastic Syndrome
68 (.67%)
White Blood Cell Count Decreased
66 (.65%)
Bone Marrow Failure
65 (.64%)
Septic Shock
62 (.61%)
Dyspnoea
61 (.6%)
Haemoglobin Decreased
60 (.59%)
Diarrhoea
57 (.56%)
Renal Failure
57 (.56%)
Convulsion
52 (.51%)
Alopecia
51 (.5%)
Drug Interaction
51 (.5%)
Hypokalaemia
51 (.5%)
Platelet Count Decreased
51 (.5%)
Epistaxis
50 (.49%)
Hearing Impaired
50 (.49%)
Respiratory Failure
50 (.49%)
Renal Impairment
49 (.48%)
Drug Toxicity
47 (.46%)
Hypotension
47 (.46%)
Somnolence
47 (.46%)
Fatigue
45 (.44%)
Asthenia
43 (.42%)
Disease Progression
43 (.42%)
Stomatitis
42 (.42%)
Tachycardia
42 (.42%)
Dehydration
40 (.4%)
Premature Baby
40 (.4%)
Weight Decreased
39 (.39%)
Blood Creatinine Increased
38 (.38%)
Disorientation
38 (.38%)
Malignant Neoplasm Progression
35 (.35%)
Neutropenic Sepsis
35 (.35%)
Off Label Use
35 (.35%)
Tremor
35 (.35%)
Drug Exposure During Pregnancy
34 (.34%)
Drug Ineffective
33 (.33%)
Interstitial Lung Disease
33 (.33%)
Agitation
31 (.31%)
Haemodialysis
31 (.31%)
Neuropathy Peripheral
31 (.31%)
Neutrophil Count Decreased
31 (.31%)
Stem Cell Transplant
31 (.31%)
Thyroid Cancer
31 (.31%)
Abdominal Pain
30 (.3%)
Aspartate Aminotransferase Increase...
30 (.3%)
Decreased Appetite
30 (.3%)
Fanconi Syndrome
30 (.3%)
Gastrointestinal Haemorrhage
30 (.3%)
Hyponatraemia
30 (.3%)
Ototoxicity
30 (.3%)
Hallucination
29 (.29%)
Mental Status Changes
29 (.29%)
Haematotoxicity
28 (.28%)
Hepatotoxicity
28 (.28%)
Pleural Effusion
28 (.28%)
Agranulocytosis
27 (.27%)
Alanine Aminotransferase Increased
27 (.27%)
General Physical Health Deteriorati...
27 (.27%)
Hypertension
27 (.27%)
Multi-organ Failure
27 (.27%)
Tumour Lysis Syndrome
27 (.27%)
Pneumothorax
26 (.26%)
Acute Lymphocytic Leukaemia
25 (.25%)
Leukoencephalopathy
25 (.25%)
Lymphopenia
25 (.25%)
Myoclonus
25 (.25%)
Pneumonitis
25 (.25%)
Blood Culture Positive
24 (.24%)
Headache
24 (.24%)
Neoplasm Malignant
24 (.24%)
Urinary Incontinence
24 (.24%)
Acute Respiratory Distress Syndrome
23 (.23%)
Neoplasm Progression
23 (.23%)
Neuralgia
23 (.23%)
Haematuria
22 (.22%)
Nephropathy Toxic
22 (.22%)
Oedema Peripheral
22 (.22%)
Renal Tubular Disorder
22 (.22%)
Staphylococcal Infection
22 (.22%)
Ascites
21 (.21%)
Cardiotoxicity
21 (.21%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Ifosfamide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ifosfamide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Ifosfamide

What are the most common Ifosfamide adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Ifosfamide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ifosfamide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Ifosfamide According to Those Reporting Adverse Events

Why are people taking Ifosfamide, according to those reporting adverse events to the FDA?

Bone Sarcoma
205
Diffuse Large B-cell Lymphoma
202
Sarcoma
191
Non-hodgkins Lymphoma
150
Burkitts Lymphoma
145
Ewings Sarcoma
125
Show More Show More
Rhabdomyosarcoma
124
Lymphoma
94
Hodgkins Disease
86
Germ Cell Cancer
76
Sarcoma Metastatic
70
Chemotherapy
65
B-cell Lymphoma
54
Neoplasm Malignant
48
Testis Cancer
44
T-cell Lymphoma Stage Iv
42
Product Used For Unknown Indication
39
Neoplasm
36
Medulloblastoma
34
Acute Lymphocytic Leukaemia
32
Drug Use For Unknown Indication
30
Non-hodgkins Lymphoma Unspecified H...
22
Synovial Sarcoma
22
Cervix Carcinoma
20
Nephroblastoma
20
Liposarcoma
18
T-cell Lymphoma
17
Pelvic Neoplasm
17
Uterine Cancer
17
Spindle Cell Sarcoma
17
Leiomyosarcoma
17
Burkitts Leukaemia
17
B-cell Type Acute Leukaemia
16
Osteosarcoma Metastatic
13
Malignant Neoplasm Progression
13
Testicular Neoplasm
13
Ovarian Cancer
13
Mantle Cell Lymphoma
13
Ewings Sarcoma Metastatic
13
Metastases To Lung
12
Neuroblastoma
12
Sarcoma Uterus
11
Central Nervous System Lymphoma
11
Head And Neck Cancer
11
Foetal Exposure During Pregnancy
10
Malignant Fibrous Histiocytoma
10
Drug Exposure During Pregnancy
9
Non-hodgkins Lymphoma Stage Iv
9
Nongerminomatous Germ Cell Tumour O...
8
B Precursor Type Acute Leukaemia
8
Lymphocytic Leukaemia
8

Drug Labels

LabelLabelerEffective
IfosfamideBedford Laboratories19-MAR-10
IfosfamideAPP Pharmaceuticals, LLC20-JAN-12
IfosfamideBaxter Healthcare Corporation01-MAR-12
IfexBAXTER HEALTHCARE CORPORATION08-MAR-12
IfosfamideAPP Pharmaceuticals, LLC31-AUG-12
IfosfamideTeva Parenteral Medicines, Inc.02-OCT-12
Ifosfamide And MesnaTeva Parenteral Medicines, Inc17-DEC-12
IfosfamidePfizer Laboratories Div Pfizer Inc.23-FEB-13

Ifosfamide Case Reports

What Ifosfamide safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Ifosfamide. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Ifosfamide.